The estimated Net Worth of Syed T Kamal is at least $43.8 Milion dollars as of 1 June 2020. Mr. Kamal owns over 416,720 units of American Renal Associates stock worth over $42,850,903 and over the last 9 years he sold ARA stock worth over $0. In addition, he makes $947,138 as President, Co-Founder oraz Director at American Renal Associates.
Sign up
Mr. Kamal ARA stock SEC Form 4 insiders trading
Syed has made over 2 trades of the American Renal Associates stock since 2016, according to the Form 4 filled with the SEC. Most recently he exercised 416,720 units of ARA stock worth $533,402 on 1 June 2020.
The largest trade he's ever made was exercising 416,720 units of American Renal Associates stock on 1 June 2020 worth over $533,402. On average, Syed trades about 46,358 units every 166 days since 2016. As of 1 June 2020 he still owns at least 1,192,290 units of American Renal Associates stock.
You can see the complete history of Mr. Kamal stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Syed Kamal biography
Syed T. Kamal serves as President, Co-Founder, Director of the Company. Mr. Kamal also served as Executive Vice President from 1999 to 2005. Mr. Kamal has nearly 40 years of experience in the dialysis services industry. Prior to co-founding our company, Mr. Kamal served in various management roles at Fresenius Medical Care North America (“FMCNA”), including as President of FMCNA’s southern business unit, Vice President of Operations for FMCNA’s North America division, Director and Vice President of Operations for FMNCA’s International division and Regional Manager of FMNCA’s Mid Atlantic and Southeast regions (U.S.). Mr. Kamal holds a B.A. in Economics and Statistics and an M.B.A. from the University of Punjab in Pakistan. Mr. Kamal brings to the Board his experience as an executive in the dialysis services industry, in addition to his providing a management perspective to Board deliberations and valuable information about the status of our day to day operations given his role as our President.
What is the salary of Syed Kamal?
As the President, Co-Founder oraz Director of American Renal Associates, the total compensation of Syed Kamal at American Renal Associates is $947,138. There are 3 executives at American Renal Associates getting paid more, with Don Williamson having the highest compensation of $1,772,140.
How old is Syed Kamal?
Syed Kamal is 68, he's been the President, Co-Founder oraz Director of American Renal Associates since . There are 2 older and 9 younger executives at American Renal Associates. The oldest executive at American Renal Associates Holdings Inc. is Robert Fish, 69, who is the Independent Director.
What's Syed Kamal's mailing address?
Syed's mailing address filed with the SEC is C/O ARAH, INC., 500 CUMMINGS CENTER, SUITE 6550, BEVERLY, MA, 01915.
Insiders trading at American Renal Associates
Over the last 9 years, insiders at American Renal Associates have traded over $0 worth of American Renal Associates stock and bought 2,870 units worth $63,140 . The most active insiders traders include Thomas W Erickson, Joseph A Carlucci oraz Syed T Kamal. On average, American Renal Associates executives and independent directors trade stock every 215 days with the average trade being worth of $4,293,860. The most recent stock trade was executed by Joseph A Carlucci on 9 June 2020, trading 416,720 units of ARA stock currently worth $533,402.
What does American Renal Associates's logo look like?
Complete history of Mr. Kamal stock trades at American Renal Associates
American Renal Associates executives and stock owners
American Renal Associates executives and other stock owners filed with the SEC include:
-
Don Williamson,
Chief Operating Officer, Executive Vice President -
Thomas Erickson,
Independent Director -
Joseph Carlucci,
Chairman of the Board, Chief Executive Officer, Co-Founder -
Syed Kamal,
President, Co-Founder, Director -
John Jureller,
Independent Director -
Michael Boxer,
Independent Director -
Robert Fish,
Independent Director -
Christopher Hocevar,
Independent Director -
Jeremy Gelber,
Independent Director -
Darren Lehrich,
SVP Strategy & Investor Relations -
Jared Hendricks,
Independent Director -
Susanne Clark,
Independent Director -
Mark Herbers,
Interim Chief Financial Officer, Interim Chief Accounting Officer -
Jason Boucher,
Former VP & CFO -
Patrick T Ryan,
Director -
John J Mcdonough,
EVP, COO AND TREASURER -
Michael Ray Costa,
VP and General Counsel -
Jonathan L Wilcox,
VP & Chief Financial Officer -
Victoria Labriola,
VP and General Counsel -
Capital Partners L Pcenterb...,